-
CAF Lactate, ANTXR1 Lactylation, and Oxaliplatin Resistance
2026-08-22
A 2025 Cancer Letters study identifies a CAF–cancer lactate circuit that promotes colorectal cancer stemness and oxaliplatin resistance through ANTXR1 transcriptional activation and lysine 453 lactylation. Its combination of molecular mechanism, functional drug-response testing, and xenograft validation supports tumor–stroma metabolic communication as a therapeutic research direction, while leaving clinical translation and patient-level heterogeneity unresolved.
-
Prestained Protein Marker: UV Stress Assay Guide
2026-08-22
Use a Triple color protein ladder to track electrophoresis, assess transfer, and interpret stress-response immunoblots from 10–250 kDa. Its EDTA-free format is especially useful when Phosbind gels or fluorescent membrane imaging must be integrated without adding chelating agents.
-
Psora 4: Beyond Simple Kv1.3 Blockade
2026-08-21
Psora 4 is more than a potent Kv1.3 blocker: it is a tool for testing how channel architecture, immune-cell state, assay timing, and disease context shape pharmacological interpretation. This article connects mechanistic research on T cell Ca2+ signaling with translational study design while defining the boundaries of what current evidence can support.
-
A-1155463: From BCL-XL Biology to Assay Design
2026-08-20
The BCL-XL inhibitor A-1155463 helps convert apoptotic priming into a testable framework for cancer models. This article connects its selective pharmacology with glioblastoma findings and provides a decision-focused strategy for interpreting mitochondrial apoptosis assays.
-
Tacalcitol monohydrate Research Workflows
2026-08-20
Tacalcitol monohydrate links VDR-directed keratinocyte biology and NGF induction with a practical colorectal cancer combination workflow. This guide covers exposure design, 5-fluorouracil pairing, mechanistic readouts, formulation controls, and troubleshooting for reproducible bench studies.
-
Caspase-3/7 Inhibitor I in Infection Models
2026-08-19
Caspase-3/7 Inhibitor I offers a reversible way to test whether infection-associated cell death depends on executioner caspases. This article translates Candida krusei apoptosis findings into a rigorous, pathway-discriminating assay strategy.
-
Luminescent ATP Detection Assay Kit for UC
2026-08-19
This practical guide shows how a luminescent ATP workflow can add a functional bioenergetic endpoint to ulcerative colitis studies centered on the NOX2/ROS/mitochondria/NLRP3 axis. It covers tissue and cell preparation, assay optimization, normalization, troubleshooting, and how to interpret ATP data alongside inflammatory, mitochondrial, and microbiota measurements.
-
Angiotensin (1-7): Mechanism and Research Use
2026-08-18
Angiotensin (1-7), also written Ang-(1-7), is an endogenous heptapeptide that counter-regulates selected angiotensin II effects through the Mas receptor. This article defines its biochemical origin, pathway-level mechanisms, evidence benchmarks, and practical handling limits for Angiotensin (1-7) peptide for research.
-
Perifosine (KRX-0401): Akt Pathway Guide
2026-08-18
Perifosine, also known as KRX-0401, is a synthetic alkylphospholipid Akt inhibitor used to study cancer-cell survival, apoptosis, and radiation sensitization. Product-reported benchmarks include a 4.7 μM Akt IC50, apoptosis-associated caspase and PARP cleavage, and antitumor activity in multiple preclinical models.
-
Adiponectin Reduces Cognitive Deficits After Splenectomy
2026-08-17
This study identifies adiponectin as a potential modulator of splenectomy-associated cognitive impairment in aged rats and links its effects to suppression of the TLR4/MyD88/NF-κB pathway. By combining behavioral testing with pharmacological pathway perturbation and hippocampal molecular assays, the work connects peripheral surgical trauma with neuroinflammation, oxidative stress, and memory dysfunction.
-
DNase I (RNase-free): Mechanism and Workflow
2026-08-17
DNase I (RNase-free) is a calcium-dependent endonuclease for controlled digestion of single-stranded and double-stranded DNA. The K1088 formulation supports DNA removal for RNA extraction, removal of DNA contamination in RT-PCR, and in vitro transcription sample preparation when cation conditions and downstream cleanup are managed carefully.
-
AICAR Phosphate: From AMPK to Translational Insight
2026-08-16
A mechanistic and strategic guide to using AICAR phosphate (Acadesine) to connect AMPK activation with mitochondrial quality control, apoptosis, and translational assay design.
-
Atrial Natriuretic Peptide: Applied Research Workflows
2026-08-15
Build reproducible cardiovascular, renal, and adipose assays around a well-characterized ANP peptide hormone while avoiding common formulation and interpretation errors. This workflow also shows how the reference study’s causal, multi-readout design can strengthen ANP experiments without confusing ANP with adiponectin.
-
CDK9 inhibitor A3294: Protocol and QC Guide
2026-08-14
CDK9 inhibitor A3294 is a selective serine/threonine kinase inhibitor for controlled studies of CDK9, transcription elongation, and HIV-1 propagation inhibition. It is appropriate for targeted biochemical or cellular workflows, but not for broad CDK inhibition, therapeutic conclusions, or long-term storage of prepared solutions.
-
GlycoRNA–RBP Domains Shape TAT Peptide Entry
2026-08-14
This bioRxiv study presents evidence that cell-surface RNA-binding proteins and glycoRNAs assemble into nanoclusters that regulate cellular interaction with the cell-penetrating peptide TAT. By combining surface localization, extracellular RNase perturbation, and uptake experiments, the work expands the cell-surface interactome beyond conventional membrane proteins while identifying an RNA-dependent entry pathway.